FDA warns Fresenius Medical Care Holdings about Quality System regulations violations in its work as a specification developer for the companys North ...
FDA warns Takilma, OR-based East Fork Cultivars about marketing misbranded unapproved new drugs containing cannabidiol.
FDA publishes a question-and-answer guidance on requirements for the major statement in direct-to-consumer broadcast ads.
FDA warns Miami, FL-based Dextrum Laboratories about CGMP violations in its production of finished drugs.
FDA approves an updated Boxed Warning for Janssen/Legend Biotechs Carvykti to state that secondary cancers have occurred in about 10% of patients rece...
FDA publishes an immediately effective guidance intended to expedite the reformulation of drug products containing carbomers manufactured with benzene...
FDA says Hospira recalled one lot of each of three injection products due to the possible presence of glass particulate matter.
FDA warns El Paso, TX-based Botanical Be about marketing products labeled as dietary supplements that legally are misbranded, unapproved new drugs tha...
